Chemotherapy: Induction of stress responses

Endocrine-Related Cancer

Volumn 13, Issue SUPPL. 1, 2006, Pages

  Tiligada, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMSACRINE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; COLCHICINE; DACTINOMYCIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; HEAT SHOCK PROTEIN; IRINOTECAN; MERCAPTOPURINE; METHOTREXATE; MITOMYCIN C; NAVELBINE; OMEPRAZOLE; PACLITAXEL; PREDNISOLONE; STAT PROTEIN; TAMOXIFEN; TENIPOSIDE; VINBLASTINE; VINCRISTINE;

CANCER RESEARCH; CELL DEATH; CELL SURVIVAL; CHEMOTHERAPY; CONFERENCE PAPER; DNA DAMAGE; DRUG MECHANISM; EUKARYOTIC CELL; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS;

ADAPTATION, BIOLOGICAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; ENDOCRINE SYSTEM; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASES;

EID: 33846879160     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01272     Document Type: Conference Paper

References (53)

1. Benhar M, Dalyot I, Engelberg D & Levitzki A 2001 Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Molecular and Cellular Biology 21 6913-6926.
2. Bensaude O, Bellier S, Dubois MF, Giannoni F & Nguyen VT 1996 Heat-shock induced protein modifications and modulation of enzyme activities. EXS 77 199-219.
3. Blagosklonny MV 2005 Carcinogenesis, cancer therapy and chemoprevention. Cell Death and Differentiation 12 592-602.
4. Calderwood SK, Khaleque MA, Sawyer DB & Ciocca DR 2006 Heat shock proteins in cancer: chaperones of tumorigenesis. Trends in Biochemical Sciences 31 164-172.
5. Ciocca DR & Calderwood SK 2005 Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10 86-103.
6. Delitheos A, Karavokyros I & Tiligada E 1995 Response of Saccharomyces cerevisiae strains to antineoplastic agents. Journal of Applied Bacteriology 79 379-383.
7. Feder ME & Hofmann GE 1999 Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annual Review of Physiology 61 243-282.
8. Goetz MP, Toft DO, Ames MM & Erlichman C 2003 The Hsp90 chaperone complex as a novel target for cancer therapy. Annals of Oncology 14 1169-1176.
9. Gururaj AE, Rayala SK, Vadlamudi RK & Kumar R 2006 Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clinical Cancer Research 12 1001s-1007s.
10. Hall BL, Smit-McBride Z & Privalsky ML 1993 Reconstitution of retinoid X receptor function and combinatorial regulation of other nuclear hormone receptors in the yeast Saccharomyces cerevisiae. PNAS 90 6929-6933.
11. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70.
12. Herr I & Debatin KM 2001 Cellular stress response and apoptosis in cancer therapy. Blood 98 2603-2614.
13. Jaattela M 1999 Heat shock proteins as cellular lifeguards. Annals of Medicine 31 261-271.
14. Keyse SM 2000 Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Current Opinion in Cell Biology 12 186-192.
15. Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y, Yoshida T, Matsuo K, Miyamoto N & Izumi H 2005 Transcription factors and drug resistance. European Journal of Cancer 41 2577-2586.
16. Kultz D 2005 Molecular and evolutionary basis of the cellular stress response. Annual Review of Physiology 67 225-257.
17. Linder S & Shoshan M 2005 Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy. Drug Resistance Updates 8 199-204.
18. Luo JL, Kamata H & Karin M 2005 IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. Journal of Clinical Investigation 115 2625-2632.
19. Marx J 2002 Demolition crew gets a hand from chaperones. Science 296 2125.
20. Matsuo K, Kohno K, Sato S, Uchiumi T, Tanimura H, Yamada Y & Kuwano M 1993 Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells. Cancer Research 53 1085-1090.
21. Miligkos V, Tiligada E, Papamichael K, Ypsilantis E & Delitheos A 2000 Anticancer drugs as inducers of thermotolerance in yeast. Folia Microbiologica 45 339-342.
22. Nadin SB, Vargas-Roig LM, Cuello-Carrion FD & Ciocca DR 2003 Deoxyribonucleic acid damage induced by doxorubicin in peripheral blood mononuclear cells: possible roles for the stress response and the deoxyribonucleic acid repair process. Cell Stress Chaperones 8 361-372.
23. Nicholson RI & Johnston SR 2005 Endocrine therapy - current benefits and limitations. Breast Cancer Research and Treatment 93 S3-S10.
24. Nicholson RI, Staka C, Boyns F, Hutcheson IR & Gee JMW 2004 Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. Endocrine-Related Cancer 11 623-641.
25. Panaretou B & Piper PW 1992 The plasma membrane of yeast acquires a novel heat-shock protein (hsp30) and displays a decline in proton-pumping ATPase levels in response to both heat shock and the entry to stationary phase. European Journal of Biochemistry 206 635-640.
26. Pantos C, Malliopoulou V, Varonos DD & Cokkinos DV 2004 Thyroid hormone and phenotypes of cardioprotection. Basic Research in Cardiology 99 101-120.
27. Papamichael K, Vovou I, Miligkos V, Stavrinidis E, Delitheos A & Tiligada E 2006 Effect of the hsp90 modulators on the heat shock response in eukaryotic cells. Folia Microbiologica 51 33-37.
28. Sanchez-Prieto R, Rojas JM, Taya Y & Gutkind JS 2000 A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Research 60 2464-2472.
29. Santoro MG 2000 Heat shock factors and the control of the stress response. Biochemical Pharmacology 59 55-63.
30. Shain KH, Landowski TH & Dalton WS 2000 The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance. Current Opinion in Oncology 12 557-563.
31. Shen DW, Liang XJ, Suzuki T & Gottesman MM 2006 Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and heat shock protein 10 that confer cisplatin resistance. Molecular Pharmacology 69 1383-1388.
32. Stavrinidis E, Delitheos A & Tiligada E 2002 Induction of morphological alterations by antineoplastic agents in yeast. Folia Microbiologica 47 157-160.
33. Stephanou A & Latchman DS 1999 Transcriptional regulation of the heat shock protein genes by STAT family transcription factors. Gene Expression 7 311-319.
34. Szabo D, Keyzer H, Kaiser HE & Molnar J 2000 Reversal of multidrug resistance of tumor cells. Anticancer Research 20 4261-4274.
35. Tiligada E 2006 Nuclear translocation during the cross-talk between cellular stress, cell cycle and anticancer agents. Current Medicinal Chemistry 13 1317-1320.
36. Tiligada E & Delitheos A 1993 Involvement of potassium ions in the action of various antineoplastic drugs on the growth of Saccharomyces cerevisiae. Letters in Applied Microbiology 16 251-253.
37. Tiligada E, Giannakakou P, Karavokyros I & Delitheos A 1996 Effect of calcium channel blockers on the action of various antitumour agents in the yeast Saccharomyces cerevisiae. Journal of Applied Bacteriology 81 481-485.
38. Tiligada E, Stavrinidis E & Delitheos A 1997 Effect of tamoxifen in lower eukaryotic cells. Anticancer Research 17 4098.
39. Tiligada E, Miligkos V, Ypsilantis E, Papamichael K & Delitheos A 1999a Molybdate induces thermotolerance in yeast. Letters in Applied Microbiology 29 77-80.
40. Tiligada E, Stavrinidis E, Manolis C & Delitheos A 1999b Effects of chromatin function inhibitors on yeast whole cells and spheroplasts. Alternatives to Laboratory Animals: ATLA 27 951-956.
41. Tiligada E, Miligkos V & Delitheos A 2002 Cross-talk between cellular stress, cell cycle and anticancer agents: mechanistic aspects. Current Medicinal Chemistry Anti-cancer Agents 2 553-566.
42. Tiligada E, Papamichael K, Vovou I & Delitheos A 2006 Circumvention of camptothecin-induced resistance during the adaptive cellular stress response. Anticancer Research 26 421-425.
43. Tomida A & Tsuruo T 1999 Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anti-cancer Drug Design 14 169-177.
44. Troester MA, Hoadley KA, Parker JS & Perou CM 2004 Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines. Environmental Health Perspectives 112 1607-1613.
45. Vanaja DK, Grossmann ME, Celis E & Young CY 2000 Tumor prevention and antitumor immunity with heat shock protein 70 induced by 15-deoxy-delta 12,14-prostaglandin J2 in transgenic adenocarcinoma of mouse prostate cells. Cancer Research 60 4714-4718.
46. Vargas-Roig LM, Gago FE, Tello O, Aznar JC & Ciocca DR 1998 Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. International Journal of Cancer 79 468-475.
47. Vilaboa NE, Galan A, Troyano A, de Blas E & Aller P 2000 Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1). Journal of Biological Chemistry 275 24970-24976.
48. Vovou I, Delitheos A & Tiligada E 2003 Does ion trafficking contribute to survival under severe stress in the eukaryotic cell? British Journal of Pharmacology 138 72P.
49. Vovou I, Delitheos A & Tiligada E 2004 The heat shock response is dependent on the external environment and on rapid ionic balancing by pharmacological agents in Saccharomyces cerevisiae. Journal of Applied Microbiology 96 1271-1277.
50. Workman P & Maloney A 2002 HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opinion on Biological Therapy 2 3-24.
51. Yamazaki H, Dilworth A, Myers CE & Sinha BK 1993 Suramin inhibits DNA damage in human prostate cancer cells treated with topoisomerase inhibitors in vitro. Prostate 23 25-36.
52. Yan Y, Weaver VM & Blair IA 2005 Analysis of protein expression during oxidative stress in breast epithelial cells using a stable isotope labeled proteome internal standard. Journal of Proteome Research 4 2007-2014.
53. Yanamandra N, Colaco NM, Parquet NA, Buzzeo RW, Boulware D, Wright G, Perez LE, Dalton WS & Beaupre DM 2006 Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia. Clinical Cancer Research 12 591-599.